The performance of growth charts in well term newborns in screening for hypoglycemia

Marwa A Khalil1,2, Samantha D'Aversa2, Tara Lozy2,3

  • 1Department of Pediatrics, Division of Neonatology, Hackensack University Medical Center, Hackensack, NJ, USA.

Insights

The WHO Growth Chart (WGC) is more sensitive than the Fenton Growth Chart (FGC) for identifying hypoglycemia risk in newborns. Agreement between the charts was poor, highlighting WGC

Area of Science:

  • Neonatal Medicine
  • Pediatric Endocrinology
  • Clinical Pediatrics

Background:

  • Hypoglycemia is a common concern in term newborns.
  • Accurate identification of at-risk infants is crucial for timely intervention.
  • Existing growth charts, like the Fenton Growth Chart (FGC) and WHO Growth Chart (WGC), are used to assess infant size and identify potential risks.

Purpose of the Study:

  • To compare the diagnostic performance of the Fenton Growth Chart (FGC) and the WHO Growth Chart (WGC) in identifying term infants at risk for hypoglycemia.
  • To evaluate the agreement between FGC and WGC in classifying infants based on size for hypoglycemia screening.

Main Methods:

  • A retrospective study design was employed.
  • Infants were screened for hypoglycemia based on Small for Gestational Age (SGA) or Large for Gestational Age (LGA) status determined by either FGC or WGC.
  • Data from 970 infants were analyzed to compare the sensitivity and specificity of the two growth charts.

Main Results:

  • There was a low agreement (47.7%) between the FGC and WGC.
  • Out of 970 infants, 29.2% developed hypoglycemia.
  • The WGC demonstrated higher sensitivity in detecting all categories of hypoglycemia (e.g., 81.3% vs. 72.4% for general hypoglycemia) compared to the FGC, while the FGC showed higher specificity.

Conclusions:

  • The WGC is more sensitive than the FGC for detecting hypoglycemia in term infants.
  • Poor agreement exists between the FGC and WGC for identifying hypoglycemia risk.
  • The WGC is a potentially superior tool for screening term infants for hypoglycemia due to its higher sensitivity.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
337
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.1K